Month: December 2019

The Sackler family – owners of Purdue Pharma – transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker.

…read more […]

Goldman Sachs Group Inc outlined plans on Monday to put money and advice toward projects that fight climate change or help financially disadvantaged people, with executives arguing it is not only the right thing to do but can generate income.

…read more […]

Oil prices trickled a fraction lower on Tuesday but remained near a three-month high as investors kept the faith with hopes that a fully fledged U.S.-China trade deal is in the pipeline and set to stoke oil demand in the world’s biggest economies.

…read more […]

Amazon.com Inc is temporarily blocking third-party sellers from using FedEx Corp’s ground delivery network to handle Prime shipments as it strives to hit accelerated delivery deadlines this holiday season.

…read more […]

Boeing Co bowed to a growing cash squeeze by suspending commercial 737 production from January for the first time in more than 20 years, as the grounding of the planemaker’s best-selling MAX after two fatal crashes drags into 2020.

…read more […]

Asian shares gained on Tuesday, but a lack of detail about the Sino-U.S. trade deal tempered some of the exuberance that sent Wall Street to record highs overnight, while familiar fears of a hard Brexit knocked the pound.

…read more […]

Goldman Sachs Group Inc said on Monday it will provide $750 billion in financing, advisory services and investments for green projects and companies, as well as those that foster economic opportunities for under-served people over the next decade.

…read more […]

Wall Street stocks notched record closing highs on Monday as cooling trade tensions between Washington and Beijing and upbeat economic data from China boosted investor sentiment.

…read more […]

Australia’s banking regulator will use its increased investigative powers for the first time to examine whether Westpac Banking Corp directors and executives broke the law as part of the bank’s money laundering scandal.

…read more […]

Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics clearing the way for Roche’s push into treating rare diseases including hemophilia A.

…read more […]